Novartis Investigative Site

Osnabrück, Lower Saxony 49076

0 studies enrolling now · 1 studies all time

What they study most

Relapsing Multiple Sclerosis

Studies at this site

• An Open-label Study Evaluating Ofatumumab Treatment Effectiveness and PROs in Subjects With RMS Transitioning From Fumarate-based RMS Approved Therapies or Fingolimod to Ofatumumab — Completed